Siegfried Group is a leading independent provider of custom process development, scale-up and commercial manufacture of active pharmaceutical ingredients and advanced pharmaceutical intermediates as well as a manufacturer of non-patented standard APIs with its manufacturing capacities being located in Switzerland and the United States.
In addition, Siegfried is not only a recognized developer of dossier for and supplier of drug products with development and manufacutring capacities in Switzerland and Malta but also a provider of challenging contract development and contract manufacturing of solid applications and a range of related services.
The Siegfried Group is a worldwide life science company with production sites in Switzerland, Malta and the U.S. and an office in China.
Siegfried offers for drug products: contract manufacturing of oral solida, contract development of complex formulation (all forms) and portfolio of drug product under its own IP for licensing out . For drug substance: a wide opiate portfolio developed under its own IP as well as custom process development, scale-up and commercial manufacturing of APIs and advanced pahrmaceutical intermediates.Out-licensed portfolio & partnership development
As an internationally renowned outsourcing partner, you can expect more from Siegfried. Siegfried provides specialized products and tailored services that fit smoothly into our customers' value chain. We offer our pharmaceutical partners a comprehensive bundle of services ranging from development of drug products, Registration and manufacturing to packaging and logistics.
Having built up our own portfolio of drug products, Siegfried is working on numerous R&D projects together with our pharmaceutical partners, which will be available for licensing. We offer a breadth of knowledge and expertise in complex oral drug delivery systems combined with complex bridging technologies such as Spray Drying.
With a focus on solid oral dosage forms with modified release of the active ingredient, Siegfried supplies leading pharmaceuticals companies worldwide. We have selected products commercially available with others actively in development. Also, Siegfried assembles complete registration dossiers and offers for all products a Common Technical Document (CTD).
- Core Sales Territory:
Global Regulated Markets
- Formed: 1873
- Number of employees: 700